Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

When a U.S. president threatens your industry with a 200% tariff, that’s not typically good news. But since Tuesday, when Donald Trump said in a cabinet meeting that imported pharmaceuticals would ...